BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7165357)

  • 1. Kinetics of [14C-5] 8-methoxypsoralen distribution in rabbits.
    Malinin GI; Glew WB; Roberts WP; Townsend L; Nigra TP
    Arch Dermatol Res; 1982; 273(3-4):319-26. PubMed ID: 7165357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of [14C-5] 8-methoxypsoralen uptake by UVA irradiated and non-irradiated rabbit eye tissues.
    Malinin GI; Glew WB; Roberts WP; Nigra TP
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):223-34. PubMed ID: 7244361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin concentration of 8-methoxypsoralen, 5-methoxypsoralen and 4,5,8-trimethylpsoralen in guinea pigs.
    Park YK; Hann SK; Im S; Kim S
    J Dermatol Sci; 1993 Feb; 5(1):19-24. PubMed ID: 8485109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
    John BA; Chasseaud LF; Wood SG; Forlot P
    Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
    Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice.
    Muni IA; Schneider FH; Olsson TA; King M
    Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Methoxypsoralen levels in blood of vitiligo patients and in skin, ophthalmic fluids, and ocular tissues of the guinea pig.
    Chakrabarti SG; Halder RM; Johnson BA; Minus HR; Pradhan TK; Kenney JA
    J Invest Dermatol; 1986 Aug; 87(2):276-9. PubMed ID: 3734475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of 3H-8-MOP and its metabolites in rat organs after a single oral administration.
    Wulf HC; Andreasen MP
    J Invest Dermatol; 1981 Apr; 76(4):252-8. PubMed ID: 7205026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.
    Mays DC; Rogers SL; Guiler RC; Sharp DE; Hecht SG; Staubus AE; Gerber N
    J Pharmacol Exp Ther; 1986 Feb; 236(2):364-73. PubMed ID: 3944766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
    Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
    Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Methoxypsoralen (8-MOP) in human skin: penetration kinetics.
    Gazith J; Schalla W; Bauer E; Schaefer H
    J Invest Dermatol; 1978 Aug; 71(2):126-30. PubMed ID: 681780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and accumulation of radioactivity in mice following administration of 14C-8-MOP and 3H-8-MOP: an autoradiographic study.
    Wulf HC
    Photodermatol; 1984 Dec; 1(6):293-7. PubMed ID: 6533620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of tritium-labelled 8-methoxypsoralen in the rat, studied by whole body autoradiography.
    Wulf HC; Hart J
    Acta Derm Venereol; 1979; 59(2):97-103. PubMed ID: 84506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual variations of 8-methoxypsoralen plasma levels.
    Schäfer-Korting M; Korting HC
    Arch Dermatol Res; 1982; 272(1-2):1-7. PubMed ID: 7165313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photobiological activity of suction blister fluid from patients treated with 8-methoxypsoralen.
    Dubertret L; Averbeck D; Prognon P; Blais J; Vigny P
    Br J Dermatol; 1983 Oct; 109(4):421-7. PubMed ID: 6354243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination by bioassay of photoactive 8-methoxypsoralen in serum.
    Glew WB; Roberts WP; Malinin GI; Nigra TP
    J Invest Dermatol; 1980 Sep; 75(3):230-4. PubMed ID: 7410889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA.
    Pohl J; Christophers E
    J Invest Dermatol; 1979 Aug; 73(2):176-9. PubMed ID: 458191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and removal of 8-MOP-DNA photoadducts in keratinocytes: effects of calcium concentration and retinoids.
    Tokura Y; Edelson RL; Gasparro FP
    J Invest Dermatol; 1991 Jun; 96(6):942-9. PubMed ID: 2045683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Methoxypsoralen and long-wave ultraviolet A inhibit the release of proinflammatory mediators and cytokines from human Fc epsilon RI+ cells: an in vitro study.
    de Paulis A; Monfrecola G; Casula L; Prizio E; Di Gioia L; Carfora M; Russo I; de Crescenzo G; Marone G
    J Photochem Photobiol B; 2003 Mar; 69(3):169-77. PubMed ID: 12695031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of apoptosis induction in human cell lines by UVA and 8-MOP.
    Vowels BR; Yoo EK; Gasparro FP
    Photochem Photobiol; 1996 May; 63(5):572-6. PubMed ID: 8628747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.